14-104774548-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001382430.1(AKT1):c.633+390G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.562 in 255,446 control chromosomes in the GnomAD database, including 44,426 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.61 ( 31055 hom., cov: 34)
Exomes 𝑓: 0.49 ( 13371 hom. )
Consequence
AKT1
NM_001382430.1 intron
NM_001382430.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.80
Publications
13 publications found
Genes affected
AKT1 (HGNC:391): (AKT serine/threonine kinase 1) This gene encodes one of the three members of the human AKT serine-threonine protein kinase family which are often referred to as protein kinase B alpha, beta, and gamma. These highly similar AKT proteins all have an N-terminal pleckstrin homology domain, a serine/threonine-specific kinase domain and a C-terminal regulatory domain. These proteins are phosphorylated by phosphoinositide 3-kinase (PI3K). AKT/PI3K forms a key component of many signalling pathways that involve the binding of membrane-bound ligands such as receptor tyrosine kinases, G-protein coupled receptors, and integrin-linked kinase. These AKT proteins therefore regulate a wide variety of cellular functions including cell proliferation, survival, metabolism, and angiogenesis in both normal and malignant cells. AKT proteins are recruited to the cell membrane by phosphatidylinositol 3,4,5-trisphosphate (PIP3) after phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2) by PI3K. Subsequent phosphorylation of both threonine residue 308 and serine residue 473 is required for full activation of the AKT1 protein encoded by this gene. Phosphorylation of additional residues also occurs, for example, in response to insulin growth factor-1 and epidermal growth factor. Protein phosphatases act as negative regulators of AKT proteins by dephosphorylating AKT or PIP3. The PI3K/AKT signalling pathway is crucial for tumor cell survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating AKT1 which then phosphorylates and inactivates components of the apoptotic machinery. AKT proteins also participate in the mammalian target of rapamycin (mTOR) signalling pathway which controls the assembly of the eukaryotic translation initiation factor 4F (eIF4E) complex and this pathway, in addition to responding to extracellular signals from growth factors and cytokines, is disregulated in many cancers. Mutations in this gene are associated with multiple types of cancer and excessive tissue growth including Proteus syndrome and Cowden syndrome 6, and breast, colorectal, and ovarian cancers. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2020]
AKT1 Gene-Disease associations (from GenCC):
- Proteus syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cowden syndrome 6Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.882 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AKT1 | NM_001382430.1 | c.633+390G>C | intron_variant | Intron 8 of 14 | ENST00000649815.2 | NP_001369359.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AKT1 | ENST00000649815.2 | c.633+390G>C | intron_variant | Intron 8 of 14 | NM_001382430.1 | ENSP00000497822.1 |
Frequencies
GnomAD3 genomes AF: 0.610 AC: 92769AN: 152066Hom.: 31009 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
92769
AN:
152066
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.491 AC: 50700AN: 103262Hom.: 13371 Cov.: 0 AF XY: 0.494 AC XY: 25976AN XY: 52630 show subpopulations
GnomAD4 exome
AF:
AC:
50700
AN:
103262
Hom.:
Cov.:
0
AF XY:
AC XY:
25976
AN XY:
52630
show subpopulations
African (AFR)
AF:
AC:
3017
AN:
3404
American (AMR)
AF:
AC:
3064
AN:
4790
Ashkenazi Jewish (ASJ)
AF:
AC:
1460
AN:
3510
East Asian (EAS)
AF:
AC:
4136
AN:
6878
South Asian (SAS)
AF:
AC:
4462
AN:
8064
European-Finnish (FIN)
AF:
AC:
2201
AN:
4618
Middle Eastern (MID)
AF:
AC:
258
AN:
522
European-Non Finnish (NFE)
AF:
AC:
28919
AN:
65094
Other (OTH)
AF:
AC:
3183
AN:
6382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1166
2332
3497
4663
5829
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
286
572
858
1144
1430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.610 AC: 92871AN: 152184Hom.: 31055 Cov.: 34 AF XY: 0.613 AC XY: 45570AN XY: 74400 show subpopulations
GnomAD4 genome
AF:
AC:
92871
AN:
152184
Hom.:
Cov.:
34
AF XY:
AC XY:
45570
AN XY:
74400
show subpopulations
African (AFR)
AF:
AC:
36976
AN:
41552
American (AMR)
AF:
AC:
9756
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
1440
AN:
3472
East Asian (EAS)
AF:
AC:
3348
AN:
5162
South Asian (SAS)
AF:
AC:
3013
AN:
4828
European-Finnish (FIN)
AF:
AC:
5204
AN:
10592
Middle Eastern (MID)
AF:
AC:
137
AN:
292
European-Non Finnish (NFE)
AF:
AC:
31454
AN:
67968
Other (OTH)
AF:
AC:
1239
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1675
3350
5026
6701
8376
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
738
1476
2214
2952
3690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2301
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.